未登录

S

Sasanka M. Handunnetti

peter maccallum cancer centre and royal melbourne hospital

H指数:17

被引数:1,337

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma

维奈托克和伊布替尼诱导边缘区淋巴瘤产生持久的临床反应

IF7.1

2025-12-150

OAAI

Marginal Zone Lymphoma Is Associated with Dysregulated Peripheral Blood Immunity Which Is Not Changed By Ibrutinib-Venetoclax Treatment

滤泡外缘区淋巴瘤与调节失调的外周血免疫相关，这种免疫状态未因Ibrutinib-Venetoclax治疗而发生改变。

IF23.1

2024-11-050

PRE

Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon

IF7.1

2024-03-152

OAAI

Treatment approaches for patients with TP53-mutated mantle cell lymphoma

LANCET HAEMATOLOGY

IF17.7

2023-02-0113

PRE

Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance

IF7.1

2022-10-1353

OAAI

Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors

IF7.1

2022-01-1819

OAAI

Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition

IF7.1

2021-10-2050

OAAI

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy

IF7.1

2020-10-0816

OAAI

High Levels of Serum Angiopoietin 2 and Angiopoietin 2/1 Ratio at the Critical Stage of Dengue Hemorrhagic Fever in Patients and Association with Clinical and Biochemical Parameters

JOURNAL OF CLINICAL MICROBIOLOGY

IF5.4

2020-03-2515

OAAI

Ibrutinib, but not zanubrutinib, induces platelet receptor shedding of GPIb-IX-V complex and integrin αIIbβ3 in mice and humans

IF7.1

2019-12-2348

OA

Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies

IF5.7

2018-11-0153

PREAI

Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2018-09-2656

OAAI

Mato, Anthony R.; Roeker, Lindsey E.; Allan, John N.; Pagel, John M.; Brander, Danielle M.; Hill, Brian T.; Cheson, Bruce D.; Furman, Richard R.; Lamanna, Nicole; Tam, Constantine S.; Handunnetti, Sasanka; Jacobs, Ryan; Lansigan, Frederick; Bhavsar, Erica; Barr, Paul M.; Shadman, Mazyar; Skarbnik, Alan P.; Goy, Andre; Beach, Douglas F.; Svoboda, Jakub; Pu, Jeffrey J.; Sehgal, Alison R.; Zent, Clive S.; Tuncer, Hande H.; Schuster, Stephen J.; Pickens, Peter V.; Shah, Nirav N.; Rhodes, Joanna; Ujjani, Chaitra S.; Nabhan, Chadi

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2018-03-29345

OAAI